Related Experiment Videos
The platelet ATP and ADP receptors
C Oury1, E Toth-Zsamboki, J Vermylen
1Center for Molecular and Vascular Biology, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium.
Current Pharmaceutical Design
|March 7, 2006
Summary
Extracellular adenosine diphosphate (ADP) and adenosine triphosphate (ATP) amplify platelet activation via P2 receptors. Understanding these receptors and their signaling pathways offers potential for antithrombotic therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Hematology
Background:
- Extracellular ADP and ATP are released during vascular injury and platelet activation.
- These nucleotides signal through platelet P2 receptors, amplifying platelet aggregation.
- Key receptors include P2Y1 and P2Y12 for ADP, and P2X1 for ATP.
Purpose of the Study:
- To review recent findings on platelet ADP and ATP receptor physiology.
- To elucidate distinct downstream intracellular signaling pathways.
- To discuss pharmacological agents targeting these receptors for antithrombotic therapy.
Main Methods:
- Literature review of recent advances in P2 receptor research.
- Analysis of signaling cascades triggered by P2Y and P2X receptors.
- Examination of available agonists, antagonists, and inhibitors.
Main Results:
- P2Y1 and P2Y12 receptors mediate ADP signaling, while P2X1 mediates ATP signaling on platelets.
- These receptors operate distinctly in terms of time, distance, and signaling pathways.
- P2Y receptors are established targets for antithrombotic therapy.
Conclusions:
- Platelet P2 receptors play a crucial role in hemostasis and thrombosis.
- Understanding P2 receptor signaling provides insights into antithrombotic drug development.
- Further research into P2X1 function may reveal new therapeutic strategies.